|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets | |||||||||||
| Cash | |||||||||||
| Due from Sponsor | |||||||||||
| Prepaid expenses | |||||||||||
| Total Current Assets | |||||||||||
| Deferred offering costs | |||||||||||
| Long-term prepaid insurance | |||||||||||
| Marketable securities held in Trust Account | |||||||||||
| Total Assets | |||||||||||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT | |||||||||||
| Current liabilities | |||||||||||
| Accrued offering costs | |||||||||||
| Accrued expenses | |||||||||||
| Advance from related party | |||||||||||
| Promissory notes – related parties | |||||||||||
| Related Party | |||||||||||
| Total promissory notes – related parties | |||||||||||
| Total Current Liabilities | |||||||||||
| Deferred legal fee | |||||||||||
| Deferred underwriting fee payable | |||||||||||
| Total Liabilities | |||||||||||
| Class A ordinary shares subject to possible redemption, 8,973,728 and 28,750,000 shares at redemption value of $11.05 and $10.75 per share as of September 30, 2026 and December 31, 2025, respectively | |||||||||||
| Common Class A | |||||||||||
| Total class A ordinary shares subject to possible redemption, 8,973,728 and 28,750,000 shares at redemption value of $11.05 and $10.75 per share as of September 30, 2026 and December 31, 2025, respectively | |||||||||||
| Shareholders’ Deficit | |||||||||||
| Class ordinary shares ,value | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated deficit | |||||||||||
| Total Shareholders’ Deficit | |||||||||||
| Total Liabilities, Class A ordinary shares subject to possible redemption, and Shareholders’ Deficit |
Loading...